Promoter mutations and cellular distribution of telomerase in non-clear cell and clear cell hepatocellular carcinoma

Wan Huang(University of Pittsburgh), Zhi‐Nan Chen(Air Force Medical University)

Oncotarget

February 17, 2017

10.18632/oncotarget.15458

Cited by 13

Related Papers

CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells

|Signal Transduction and Targeted Therapy|2020|1.2k

Liver Triglyceride Secretion and Lipid Oxidative Metabolism Are Rapidly Altered by Leptin in Vivo

|Endocrinology|2005|114

RIP3 promotes colitis-associated colorectal cancer by controlling tumor cell proliferation and CXCL1-induced immune suppression

|Theranostics|2019|88

Receptor‐Interacting Protein Kinase 3 Deficiency Recruits Myeloid‐Derived Suppressor Cells to Hepatocellular Carcinoma Through the Chemokine (C‐X‐C Motif) Ligand 1–Chemokine (C‐X‐C Motif) Receptor 2 Axis

|Hepatology|2019|74

A novel small-molecule compound targeting CD147 inhibits the motility and invasion of hepatocellular carcinoma cells

|Oncotarget|2016|65